logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (i) Distribution of new outpatient clients by age group for each primary drug

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives0.68.311.411.814.513.310.729.335.5254737
Volatile substances32.141.910.
Cannabis 3.833.
Other substances


 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, LT, HU, MT, NL, PT, SK, FI, SE, UK 

 Last data available from Spain refer to year of treatment 2004.                 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-102-New outpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page


 2006 Reitox national reports - Table TDI outpatient treatment centres. 

Page last updated: Monday, 12 November 2007